Pat Fortune
About Pat Fortune
Pat Fortune is the Associate Director of Market Access at Bristol-Myers Squibb, with over 14 years of experience in the company, specializing in Immuno-Oncology and various therapeutic areas.
Title and Role at Bristol-Myers Squibb
Pat Fortune serves as the Associate Director of Market Access at Bristol-Myers Squibb. In this role, Pat leads the Immuno-Oncology Access team. A major part of the responsibilities involves preparing the local market for the entry of new products and coordinating hospital formulary applications to ensure these products become available to patients. Additionally, Pat engages in discussions with key stakeholders like HSE, NCPE, and NCCP to facilitate market access for new therapies.
Educational Background
Pat Fortune has a comprehensive education background supporting a successful career in healthcare and market access. Pat earned an MBA from Dublin Business School, studying from 2007 to 2009. Additionally, Pat achieved a Higher Diploma in Health Economics from the National University of Ireland, Maynooth, spanning 2010 to 2011. Earlier qualifications include an RGN from St James's Hospital Dublin, from 1987 to 1989, and an RPN from St. Senans Hospital, Enniscorthy, from 1982 to 1985.
Career at Bristol-Myers Squibb
Pat Fortune has been with Bristol-Myers Squibb for over 14 years, starting in April 2009. Throughout this period, Pat has taken on crucial roles within the organization, particularly in the area of market access. Pat's work primarily involves ensuring that new therapies, particularly in Immuno-Oncology, Cardiovascular, and Diabetes areas, gain swift market entry and are available to patients. This includes engaging in extensive discussions with healthcare stakeholders and generating value propositions for new products.
Expertise in Multiple Therapeutic Areas
Pat Fortune has extensive experience in multiple therapeutic areas, including Oncology, Cardiovascular, Immunotherapy, Diabetes, and Neuroscience. This vast experience contributes to a deep understanding of the complexities involved in bringing new therapies to market. Pat's role often requires the creation of compelling value propositions and managing the coordination of hospital formulary applications to ensure timely patient access to innovative treatments.